Andere talen Kissei Pharmaceutical Co., Ltd.

Aandelen

4547

JP3240600001

Vertraagde tijd Japan Exchange Andere beurzen 04:30:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3.540 ^JPY	+0,14%		+3,51%	+14,56%

04/01	Kissei Pharmaceutical koopt 251 miljoen yen aan aandelen terug in december 2023	MT
2023	Kissei Pharmaceutical Co., Ltd. en Maruishi Pharmaceutical Co., Ltd. kondigt aan dat KORSUVA®? IV Injectiespuit voor Dialyse 17,5ug, 25,0ug in Japan op de markt voor de behandeling van pruritus bij patiënten die Hemodialyse ondergaan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program	20/03
Kissei Pharmaceutical : Notice Concerning Status of Acquisition and Completion of the Company's Own Shares	19/03
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	19/03
Kissei Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 8, 2023, has closed with 1,909,900 shares, representing 4.18% for ¥5,999.99 million.	18/03
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/03
Kissei Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 2024	30/01
Kissei Pharmaceutical Repurchases 251 Million Yen Worth of Shares in December 2023	04/01
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	04/01
Kissei and Maruishi Debut Injection for Dialysis-Related Itching	13/12
Kissei Pharmaceutical : KORSUVA® IV Injection Syringe for Dialysis 17.5μg, 25.0μg and 35.0μg to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12/12
Kissei Pharmaceutical Co., Ltd. and Maruishi Pharmaceutical Co., Ltd. Announces KORSUVA®? IV Injection Syringe for Dialysis 17.5ug, 25.0ug to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12/12
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/12
Kissei Pharmaceutical : Introduces Natural Language Processing System	17/11
Japanese Shares Close Lower on Tuesday After Key Economic Data	07/11
Kissei Pharmaceutical's Fiscal H1 Attributable Profit Surges as Net Sales Gains	07/11
Kissei Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	06/11
Kissei Pharmaceutical Co., Ltd. Announces Second Quarter-End Dividend for the Year Ending March 31, 2024, Payable on December 4, 2023 and Provided Dividend Guidance for the Year Ending March 31, 2024	06/11
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/11
Kissei Pharmaceutical Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Ending September 30, 2023	27-10-23
Kissei Pharmaceutical : Notice Concerning Revisions to Financial Results Forecast	27-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Kissei Pharmaceutical Co., Ltd.

Aandelen

4547

JP3240600001

Andere talen

Filters